🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 2-part Phase 1b study of BGB-283 (lifirafenib) and PD-0325901 (mi...
Status
Completed
Location
University of California Los Angeles
Start Date
2019-05-01
Trial ID
NCT03905148
Treatments Being Tested
MEK is a critical member of the MAPK pathway involved in growth and surviva...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2005-11
Trial ID
NCT00174369
Treatments Being Tested
This phase II open label study will evaluate adolescents (≥ 16 years of age...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-06
Trial ID
NCT02096471
Treatments Being Tested
The purpose of this study is to find out whether mirdametinib in combinatio...
Status
Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Start Date
2025-02-19
Trial ID
NCT06843967
Treatments Being Tested
This is an open-label, multi-center, Phase 1/2 study of the brain-penetrant...
Status
Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2021-06-21
Trial ID
NCT04923126
Treatments Being Tested
The goal of this clinical trial is to evaluate clinical efficacy of mirdame...
Status
Recruiting
Location
California Pacific Medical Center - Sutter Health
Start Date
2025-10-13
Trial ID
NCT07237100
Treatments Being Tested
The purpose of this study is to provide access for a single patient to PD-0...
Status
No Longer Available
Location
Sharp Healthcare
Start Date
2013-06
Trial ID
NCT02297802
Treatments Being Tested
A Phase 1/2a open-label, multicenter, dose escalation and expansion study o...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2023-02-03
Trial ID
NCT05580770
Treatments Being Tested
This research study is evaluating the experimental drug palbociclib in comb...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2014-01
Trial ID
NCT02022982
Treatments Being Tested
This trial is designed to try two new cancer drugs together for the first t...
Status
Completed
Location
Oxford University Hospital NHS Trust
Start Date
2014-11
Trial ID
NCT02510001
Treatments Being Tested